Live Breaking News & Updates on Alnylam pharmaceuticals

Stay informed with the latest breaking news from Alnylam pharmaceuticals on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Alnylam pharmaceuticals and stay connected to the pulse of your community

5 Most Promising Stocks to Buy Before They Take Off

In this article, we discuss the 5 most promising stocks to buy before they take off.

Massachusetts , United-states , Number-of-hedge-fund-holders , Alnylam-pharmaceuticals-inc , Nasdaq , Promising-stocks , Buy-before-they-take , Upside-potential , Hedge-fund-holders , Alnylam-pharmaceuticals , Venbio-select-advisor

Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Shares Sold by Motley Fool Asset Management LLC

Motley Fool Asset Management LLC reduced its position in shares of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Free Report) by 8.8% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 2,035 shares of the biopharmaceutical company’s stock after selling 196 shares during the period. Motley […]

Motley-fool-asset-management , News-ratings-for-alnylam-pharmaceuticals-daily , Wells-fargo-company , Raymond-james-associates , S-capital-wealth-advisors , Jpmorgan-chase-co , Alnylam-pharmaceuticals-stock-performance , Quarter-for-alnylam-pharmaceuticals , Exchange-commission , Alnylam-pharmaceuticals-inc , Harbor-capital-advisors-inc

BB Biotech presents solid first-quarter results; biotech stock market impacted by shifting views on interest rates

EQS-News: BB BIOTECH AG

/ Key word: Interim Report

BB Biotech presents solid first-quarter results; biotech stock market impacted by shifting views on interest rates...

Germany , Schaffhausen , Switzerland , Japan , Swiss , German , Maria-grazia-alderuccio , Erich-hunziker , Krogsgaard-thomsen , Thomas-egger , Pearl-huang , Clive-meanwell

Oligonucleotide Synthesis Market Worth $19.7 billion

Oligonucleotide Synthesis Market Worth $19.7 billion
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Northbrook , Illinois , United-states , Chicago , Japan , Iowa , United-kingdom , Ireland , Coralville , America , Maravai-lifesciences , Aashish-mehra

StockNews.com Downgrades Alnylam Pharmaceuticals (NASDAQ:ALNY) to Hold

StockNews.com Downgrades Alnylam Pharmaceuticals (NASDAQ:ALNY) to Hold
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Canada , Analyst-recommendations-for-alnylam-pharmaceuticals , Alnylam-pharmaceuticals-inc , Hedge-funds-weigh-in-on-alnylam-pharmaceuticals , Oppenheimer-co , Wells-fargo-company , Ep-wealth-advisors , Needham-company , News-ratings-for-alnylam-pharmaceuticals-daily , Commerce-bank , Harbor-capital-advisors-inc

ProQR Nominates Martin Maier, PhD to Board and Announces Annual Meeting of Shareholders to be Held May 22, 2024

LEIDEN, Netherlands & CAMBRIDGE, Mass., April 23, 2024 -- ProQR Therapeutics NV. , a company dedicated to changing lives through transformative RNA therapies based on its proprietary Axiomer™...

Netherlands , Amsterdam , Noord-holland , Germany , Bart-filius , Peter-kelleher , James-shannon , Martin-maier , Sarah-kiely , Gerard-platenburg , Theresa-heggie , Dinko-valerio

The 150 Most Influential Bostonians in 2024

Our list features Bostonians who hail from government, science, finance, healthcare, education, entertainment, and more. Who's No. 1?

Newbury , West-berkshire , United-kingdom , Beacon-hill , Massachusetts , United-states , Boston-public-library , Jamaica-plain , Chestnut-hill , Coolidge-corner , City-of-boston , Museum-of-science

Duality Advisers LP Buys 7,682 Shares of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY)

Duality Advisers LP Buys 7,682 Shares of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY)
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Wellington , New-zealand-general- , New-zealand , London , City-of , United-kingdom , Wells-fargo-company , Alnylam-pharmaceuticals-profile , Morgan-stanley , Exchange-commission , Td-asset-management-inc

ProQR Therapeutics N : AGM 2024 Explanatory Notes

2024 ANNUAL GENERAL MEETING OF SHAREHOLDERS PROQR THERAPEUTICS N.V.

Explanatory Notes to the Agenda

ProQR Therapeutics N.V. | Zernikedreef 9...

United-states , Belfast , United-kingdom , Amsterdam , Noord-holland , Netherlands , Germany , Dutch , Gerard-platenburg , James-shannon , Ernst-bayer , Martin-maier

Alnylam Pharmaceuticals (NASDAQ:ALNY) Sets New 1-Year Low at $143.50

Alnylam Pharmaceuticals (NASDAQ:ALNY) Sets New 1-Year Low at $143.50
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

China , Canada , Wolfe-research , Nasdaq , Alnylam-pharmaceuticals-inc , Alnylam-pharmaceuticals , Alnylam-pharmaceuticals-stock-performance , Citigroup , Hedge-funds-weigh-in-on-alnylam-pharmaceuticals , Jpmorgan-chase-co , China-universal-asset-management-co